Incyte Corporation (INCY) Financials

INCY Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 7.9 billion 1.5 billion
March 31, 2026 7.3 billion 1.8 billion
Dec. 31, 2025 7.0 billion 1.8 billion
Sept. 30, 2025 6.3 billion 1.7 billion

INCY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 495.2 million 67.3 million
March 31, 2026 359.2 million 64.1 million
Dec. 31, 2025 521.4 million 62.2 million
Sept. 30, 2025 544.6 million 61.6 million

INCY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 585.6 million
March 31, 2026 303.3 million
Dec. 31, 2025 299.3 million
Sept. 30, 2025 424.2 million

INCY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 4.5 billion - 38.3 million
March 31, 2026 4.0 billion - 33.8 million
Dec. 31, 2025 3.6 billion 14.5 million 44.7 million
Sept. 30, 2025 2.9 billion - 41.3 million

INCY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 208.2 million
March 31, 2026 206.8 million
Dec. 31, 2025 204.8 million
Sept. 30, 2025 201.4 million

INCY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 12.4 million 517.0 million 351.7 million -
March 31, 2026 10.2 million 515.9 million 328.1 million 328.1 million
Dec. 31, 2025 21.9 million 611.4 million 390.4 million -
Sept. 30, 2025 14.7 million 506.6 million 329.1 million -

INCY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 1.7 billion 105.0 million
March 31, 2026 1.3 billion 104.5 million
Dec. 31, 2025 1.5 billion 121.1 million
Sept. 30, 2025 1.4 billion 99.0 million

INCY Revenue by Segment
Graph available only for paid members. Upgrade to see it.

INCY

Price: $126.75

52 week price:
76.45
132.60

Earnings Per Share: 7.85 USD

P/E Ratio: 15.23

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 1.0 million

Ebitda: -135.0 million

Market Capitalization: 24.4 billion

Links: